Fenofibrate, PPARα, and the Age-Resilient Liver
2026-08-12
Fenofibrate is more than a lipid-modulating tool: it is a mechanistic probe for PPARα-driven transcription, hepatic growth responses, and PPARα–YAP pathway crosstalk. This thought-leadership article translates recent aging-mouse evidence into practical guidance for lipid metabolism research, cancer biology research, and translational study design.
YC-1: A Causal Probe for Hypoxia Research
2026-08-12
YC-1 is more than a HIF-1α inhibitor: it is a pharmacological probe for separating hypoxia signaling, sGC activity, mitochondrial quality control, and cell fate. This guide translates recent mitophagy research into a rigorous framework for cancer research and mechanistic assay design.
NSP15 Inhibitor Screening: Thymopentin and Oleuropein
2026-08-11
A 2021 structure-based study screened a natural-product library against the SARS-CoV-2 NSP15 endoribonuclease and identified thymopentin and oleuropein as the leading computational candidates. Molecular-dynamics analyses supported stable protein–ligand complexes, while the study’s in silico design also highlights the need for biochemical and cellular validation before therapeutic conclusions can be drawn.
nor-Binaltorphimine dihydrochloride: KOR Assays
2026-08-10
Explore how nor-Binaltorphimine dihydrochloride can convert a newly defined brain-to-spinal opioid circuit into a more informative κ-opioid receptor antagonist assay. This guide emphasizes causal experimental design, mechanical hypersensitivity endpoints, controls, and interpretation beyond conventional product-focused discussions.
ETS1–SENP2–FUNDC1 Axis in BPD Mitophagy
2026-08-09
The reference study identifies ETS1 as a transcriptional regulator that protects against hyperoxia-associated bronchopulmonary dysplasia by coordinating the SENP2/HSPA8/FUNDC1 pathway and limiting mitochondrial damage-induced mitophagy. Its findings connect transcriptional control, FUNDC1 SUMO1 deconjugation, and chaperone-linked degradation, while also highlighting important limits for translating this mechanism into other autophagy models.
Chlorogenic Acid–Metal Assemblies in Inflammation
2026-08-08
A 2026 Frontiers in Pharmacology study shows that iron- and copper-associated chlorogenic acid supramolecules can enhance anti-inflammatory activity relative to parent compounds in LPS-stimulated RAW264.7 macrophages. Integrated spectroscopic and mass-spectrometric characterization, mediator profiling, and pathway analysis link the effect to NF-κB inhibition and reduced iNOS and COX-2 expression.
Anlotinib hydrochloride: Assay Workflows
2026-08-07
Anlotinib hydrochloride enables mechanism-led angiogenesis experiments that connect receptor phosphorylation, endothelial behavior, and tumor-growth models. This practical guide covers concentration design, migration and tube-formation workflows, ERK pathway readouts, comparative positioning, and troubleshooting for cancer research.
Prolonging Mouse Corneal Epithelial Proliferation with 6C Me
2026-08-07
A recent study presents a novel 6C medium that extends the proliferative activity of mouse corneal epithelial cells (mCECs) in vitro and in vivo. By targeting multiple signaling pathways, including BMP inhibition via LDN-193189, this approach yields more stable progenitor populations for regenerative research and transplantation models.
Reversine as an Aurora Kinase Inhibitor: Protocols & Insight
2026-08-06
Harness Reversine for precise modulation of mitotic checkpoints and targeted inhibition of cancer cell proliferation. This article guides users through advanced experimental workflows, troubleshooting, and the latest mechanistic insights, positioning Reversine from APExBIO as a critical tool in cancer biology research.
Muco-Penetrating iLLNs Enhance Intranasal mRNA Delivery Effi
2026-08-06
The referenced study demonstrates that ionizable lipid-incorporated liquid lipid nanoparticles (iLLNs) with tunable pKa enable efficient mucosal penetration and markedly boost intranasal mRNA delivery in vivo. This approach achieves substantially higher gene expression and mucosal immune responses versus benchmark LNPs, offering new directions for respiratory vaccine development.
Deferasirox: Oral Iron Chelator Workflows for Cancer Researc
2026-08-05
Deferasirox stands out as a robust oral iron chelator for both iron overload and mechanistic cancer studies, offering precise modulation of iron metabolism and apoptosis. This article details stepwise protocols, experimental enhancements, and troubleshooting insights to maximize Deferasirox’s translational impact, spotlighting new directions from recent cell death research.
Arctigenin Inhibits Hepatocellular Carcinoma via PI3K/AKT Ta
2026-08-05
Yu et al. (2025) reveal that arctigenin, a lignan from Saussurea medusa, exerts potent anti-cancer effects in hepatocellular carcinoma by modulating the PI3K/AKT pathway. This integrative study combines network pharmacology, molecular modeling, and in vitro/in vivo validation, underscoring arctigenin’s promise for targeted cancer therapy and providing a robust framework for future PI3K/Akt/mTOR pathway inhibitor research.
Cyanine 5-dCTP: High-Fidelity Fluorescent DNA Labeling Reage
2026-08-04
Cyanine 5-dCTP (Cy5-dCTP) enables precise fluorescent labeling of DNA during enzymatic synthesis. Its robust red fluorescence, high purity, and compatibility with advanced 3D DNA frameworks make it essential for sensitive nucleic acid detection and imaging workflows.
Cediranib (AZD2171): Applied Angiogenesis Inhibition in Canc
2026-08-04
Cediranib (AZD2171) empowers cancer researchers to quantitatively dissect VEGFR-driven angiogenesis and PI3K/Akt/mTOR signaling using robust, reproducible in vitro models. This guide translates systems-level findings and workflow enhancements into actionable strategies for optimizing experimental outcomes with APExBIO's high-quality reagent.
EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1
2026-08-03
EDC.HCl (3-(ethyliminomethylideneamino)-N,N-dimethylpropan-1-amine hydrochloride) is a water-soluble carbodiimide reagent designed for efficient amide bond formation in peptide synthesis, bioconjugation, and nucleotide workflows. It is not intended for in vivo or clinical use, and its effectiveness depends on strict adherence to recommended storage and reaction protocols.
462 records 9/31 page Previous Next First page 上5页 678910 下5页 Last page